MX368037B - Colágeno modificado. - Google Patents

Colágeno modificado.

Info

Publication number
MX368037B
MX368037B MX2014008327A MX2014008327A MX368037B MX 368037 B MX368037 B MX 368037B MX 2014008327 A MX2014008327 A MX 2014008327A MX 2014008327 A MX2014008327 A MX 2014008327A MX 368037 B MX368037 B MX 368037B
Authority
MX
Mexico
Prior art keywords
collagen
modified collagen
modified
isolated
maturing
Prior art date
Application number
MX2014008327A
Other languages
English (en)
Spanish (es)
Other versions
MX2014008327A (es
Inventor
Michael Myers
Alexandra Dietrich
Original Assignee
Innocoll Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20120150527 external-priority patent/EP2612888A1/en
Priority claimed from GBGB1220868.2A external-priority patent/GB201220868D0/en
Application filed by Innocoll Pharm Ltd filed Critical Innocoll Pharm Ltd
Publication of MX2014008327A publication Critical patent/MX2014008327A/es
Publication of MX368037B publication Critical patent/MX368037B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2014008327A 2012-01-09 2013-01-09 Colágeno modificado. MX368037B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20120150527 EP2612888A1 (en) 2012-01-09 2012-01-09 A modified collagen
GBGB1220868.2A GB201220868D0 (en) 2012-11-20 2012-11-20 A modified collagen
PCT/EP2013/050333 WO2013104687A2 (en) 2012-01-09 2013-01-09 A modified collagen

Publications (2)

Publication Number Publication Date
MX2014008327A MX2014008327A (es) 2015-05-11
MX368037B true MX368037B (es) 2019-09-17

Family

ID=47559477

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008327A MX368037B (es) 2012-01-09 2013-01-09 Colágeno modificado.

Country Status (22)

Country Link
US (4) US10487134B2 (enExample)
EP (4) EP3255106B1 (enExample)
JP (3) JP6494285B2 (enExample)
AU (1) AU2013208952B2 (enExample)
CA (1) CA2860552C (enExample)
CY (3) CY1119524T1 (enExample)
DK (3) DK2802624T3 (enExample)
EA (2) EA037396B1 (enExample)
ES (3) ES2645445T3 (enExample)
HK (1) HK1244296B (enExample)
HR (3) HRP20171635T1 (enExample)
HU (3) HUE037043T2 (enExample)
LT (3) LT2802624T (enExample)
MX (1) MX368037B (enExample)
NO (1) NO2802624T3 (enExample)
PL (3) PL3255106T3 (enExample)
PT (2) PT2802624T (enExample)
RS (3) RS61726B1 (enExample)
SI (3) SI2802624T1 (enExample)
SM (3) SMT202100257T1 (enExample)
TR (1) TR201907156T4 (enExample)
WO (1) WO2013104687A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20171635T1 (hr) * 2012-01-09 2018-02-23 Innocoll Pharmaceuticals Limited Modificirani kolagen
US20180237259A1 (en) * 2017-02-22 2018-08-23 Otis Elevator Company Method for detecting trapped passengers in elevator car
RU2704248C1 (ru) * 2018-10-02 2019-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения пористого коллагенового материала
RU2760326C1 (ru) * 2021-03-04 2021-11-24 Общество с ограниченной ответственностью научно-производственное объединение «Велис» Способ получения пористого влагоемкого материала на коллагеновой основе
US20240226382A1 (en) 2021-04-12 2024-07-11 Innocoll Pharmaceuticals Limited Drug-release implant for laparoscopic surgery
CN113201569B (zh) * 2021-06-21 2022-08-30 江南大学 一种牛ⅰ型胶原蛋白的纯化方法
IL310517A (en) * 2021-07-28 2024-03-01 Innocoll Pharm Ltd Bupivacaine-collagen drug delivery implant and methods of making and using thereof
WO2023084005A1 (en) * 2021-11-12 2023-05-19 Innocoll Pharmaceuticals Limited Resorbable collagen scaffold for dural repair
WO2024079289A1 (en) 2022-10-12 2024-04-18 Innocoll Pharmaceuticals Limited A kit for implanting a drug-release implant for laparoscopic surgery
CN115975247B (zh) 2022-12-21 2024-01-30 合肥工业大学 一种抗生物污损的磁性丝素蛋白基复合气凝胶、制备方法及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246282B2 (enExample) * 1972-11-15 1977-11-24
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
US4279812A (en) 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
FR2720945B1 (fr) 1994-06-08 1996-08-30 Coletica Membrane collagénique anti-adhérence post-opératoire.
US5945125A (en) 1995-02-28 1999-08-31 Temple University Controlled release tablet
AU716137B2 (en) * 1997-01-16 2000-02-17 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20010014667A1 (en) * 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6682760B2 (en) * 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
CA2434972C (en) * 2001-01-16 2010-06-08 Vascular Therapies, Llc Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
US7396912B2 (en) * 2003-04-11 2008-07-08 Ecodynamic Biolab Collagen production method
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
SI2139457T1 (sl) * 2007-03-28 2016-09-30 Innocoll Pharmaceutical Limited Naprava za dajanje zdravila za zagotavljanje lokalne analgezije, lokalne anestezije ali živčne blokade
USRE47826E1 (en) * 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US8034368B2 (en) * 2007-03-28 2011-10-11 Innocoll Technologies Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US7820794B2 (en) 2008-09-11 2010-10-26 Sunmax Biotechnology Co., Ltd. Long-lasting collagen and manufacturing method thereof
EP2352531A2 (en) * 2008-11-06 2011-08-10 Innocoll Technologies Limited Drug delivery implants and processes for their preparation
WO2011014155A1 (en) 2009-07-27 2011-02-03 National Cheng Kung University Preparation of high purity collagen
JP2011225462A (ja) * 2010-04-16 2011-11-10 Ihara Suisan Kk 多孔質コラーゲン、その製造方法およびその用途
WO2011139228A1 (en) 2010-05-07 2011-11-10 Empire Technology Development Llc Nano scale collagen particles and membranes
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
HRP20171635T1 (hr) * 2012-01-09 2018-02-23 Innocoll Pharmaceuticals Limited Modificirani kolagen
US11623947B2 (en) * 2013-04-08 2023-04-11 Innocoll Pharmaceuticals Limited Collagen powder

Also Published As

Publication number Publication date
JP6494285B2 (ja) 2019-04-03
PL3536748T3 (pl) 2021-07-19
AU2013208952A1 (en) 2014-08-28
RS58935B1 (sr) 2019-08-30
JP2020169188A (ja) 2020-10-15
LT2802624T (lt) 2017-12-27
HUE037043T2 (hu) 2018-08-28
AU2013208952B2 (en) 2016-09-15
PL2802624T3 (pl) 2018-02-28
DK3255106T3 (da) 2019-05-20
SMT202100257T1 (it) 2021-07-12
CY1119524T1 (el) 2018-03-07
EA027745B1 (ru) 2017-08-31
EP3536748B1 (en) 2021-02-24
ES2645445T3 (es) 2017-12-05
US20190359689A1 (en) 2019-11-28
PT3255106T (pt) 2019-06-04
MX2014008327A (es) 2015-05-11
HUE043826T2 (hu) 2019-09-30
SMT201900373T1 (it) 2019-09-09
US20220213173A1 (en) 2022-07-07
EA201790763A3 (ru) 2017-11-30
LT3255106T (lt) 2019-07-25
EP3255106B1 (en) 2019-04-24
HUE054838T2 (hu) 2021-10-28
JP7213205B2 (ja) 2023-01-26
EP3536748A1 (en) 2019-09-11
SI3536748T1 (sl) 2021-08-31
SMT201700507T1 (it) 2018-01-11
SI3255106T1 (sl) 2019-09-30
HRP20190861T1 (hr) 2019-08-09
DK3536748T3 (da) 2021-05-03
CA2860552A1 (en) 2013-07-18
US11746141B2 (en) 2023-09-05
JP2015508403A (ja) 2015-03-19
EA037396B1 (ru) 2021-03-24
EA201491278A1 (ru) 2015-01-30
EP2802624A2 (en) 2014-11-19
PL3255106T3 (pl) 2019-09-30
CY1121643T1 (el) 2020-07-31
WO2013104687A2 (en) 2013-07-18
WO2013104687A3 (en) 2013-12-05
CA2860552C (en) 2020-06-16
JP6720279B2 (ja) 2020-07-08
TR201907156T4 (tr) 2019-06-21
US10487134B2 (en) 2019-11-26
PT2802624T (pt) 2017-11-10
ES2728205T3 (es) 2019-10-22
EP3255106A1 (en) 2017-12-13
RS61726B1 (sr) 2021-05-31
ES2870137T3 (es) 2021-10-26
US20170022266A1 (en) 2017-01-26
CY1124160T1 (el) 2022-05-27
EA201790763A2 (ru) 2017-07-31
NO2802624T3 (enExample) 2017-12-30
US20150011476A1 (en) 2015-01-08
HRP20210699T1 (hr) 2021-09-17
DK2802624T3 (da) 2017-11-13
EP2802624B1 (en) 2017-08-02
LT3536748T (lt) 2021-08-10
HRP20171635T1 (hr) 2018-02-23
RS56564B1 (sr) 2018-02-28
JP2019065017A (ja) 2019-04-25
HK1244296B (en) 2020-06-05
EP3901218A1 (en) 2021-10-27
SI2802624T1 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
WO2013104687A3 (en) A modified collagen
WO2013181585A3 (en) Methods related to adalimumab
AU340309S (en) Toy
SG10201900948PA (en) Modified nucleotide linkers
EP3295097A4 (en) Ice maker with push notification to indicate when maintenance is required
WO2012109215A3 (en) Apparatuses and methods for the production of microfibers and nanofibers
SG11201501968VA (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
WO2014153346A8 (en) Engineering a heterogeneous tissue from pluripotent stem cells
WO2013181586A3 (en) Methods related to bevacizumab
EP3141019A4 (en) Techniques to manage radio frequency chains
PL3102609T3 (pl) Sposoby wytwarzania autologicznych komórek t przydatnych w leczeniu nowotworów złośliwych b-komórkowych i innych nowotworów oraz ich kompozycje
PH12015500828A1 (en) A method of producing frozen confection product
IL244949A0 (en) Natural fermentation of frozen dairy desserts using a natural plant source
EP2986144A4 (en) IMPROVED MEAT BOUILLIE PRODUCTION METHODS AND COMPOSITIONS
WO2014182684A3 (en) Methods and compositions related to large scale production of proteins
PH12015501099A1 (en) Synbiotic composition and use thereof
ZA201804457B (en) Process to reduce the overall energy consumption in the production of nanocellulose
EP2900783A4 (en) DEHYDRATED GEL COMPOSITIONS AND USE METHOD THEREFOR
WO2013181599A3 (en) Methods related to rituximab
EP3182983A4 (en) Antibodies to polyphosphate decrease clot formation, decrease inflammation, and improve survival
PL2723192T3 (pl) Sposób wytwarzania odwodnionych smażonych w małej ilości tłuszczu kawałków warzyw
WO2014173416A3 (en) An aerated cheese product
IN2013MU01290A (enExample)
ZA201303881B (en) Dehydrated food product
ZA201601674B (en) Ice production plant

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: INNOCOLL PHARMACEUTICALS LIMITED

FG Grant or registration